{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:36:43Z","timestamp":1795145803078,"version":"4.10.3"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mayoclinicproceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.mayocp.2015.12.017","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T10:15:21Z","timestamp":1456827321000},"page":"386-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1016,"title":["Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment"],"prefix":"10.1016","volume":"91","author":[{"given":"Shanthi","family":"Marur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene A.","family":"Forastiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2015.12.017_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.mayocp.2015.12.017_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4065\/83.4.489","article-title":"Head and neck cancer: changing epidemiology, diagnosis, and treatment","volume":"83","author":"Marur","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.mayocp.2015.12.017_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.22963","article-title":"Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?","volume":"110","author":"Sturgis","year":"2007","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.mayocp.2015.12.017_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009-2010","volume":"307","author":"Gillison","year":"2012","journal-title":"JAMA"},{"issue":"32","key":"10.1016\/j.mayocp.2015.12.017_bib6","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.mayocp.2015.12.017_bib7","unstructured":"National Cancer Institute, Surveillance, Epidemiology, and End Results Program. SEER 9 registries, Cancer Statistics Animator. National Cancer Institute website. http:\/\/seer.cancer.gov\/canstat. Updated August 2014. Accessed March 3, 2015."},{"issue":"3","key":"10.1016\/j.mayocp.2015.12.017_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ijc.28201","article-title":"EUROGIN roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix","volume":"134","author":"Gillison","year":"2014","journal-title":"Int J Cancer"},{"issue":"36","key":"10.1016\/j.mayocp.2015.12.017_bib9","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1200\/JCO.2013.50.3870","article-title":"Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers","volume":"31","author":"Chaturvedi","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.mayocp.2015.12.017_bib10","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D'Souza","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2015.12.017_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.mayocp.2015.12.017_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.mayocp.2015.12.017_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.hoc.2008.08.006","article-title":"Human papillomavirus in HNSCC: recognition of a distinct disease type","volume":"22","author":"Vidal","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0092-8674(00)80714-X","article-title":"Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition","volume":"97","author":"Zhang","year":"1999","journal-title":"Cell"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2015.12.017_bib16","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1007\/s12105-012-0372-5","article-title":"HPV detection methods in head and neck cancer","volume":"6","author":"Venuti","year":"2012","journal-title":"Head Neck Pathol"},{"issue":"11","key":"10.1016\/j.mayocp.2015.12.017_bib17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/ijc.22980","article-title":"A\u00a0novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen","volume":"121","author":"Smeets","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2015.12.017_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/gm419","article-title":"Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma","volume":"5","author":"Lechner","year":"2013","journal-title":"Genome Med"},{"issue":"6046","key":"10.1016\/j.mayocp.2015.12.017_bib19","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"Agrawal","year":"2011","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mayocp.2015.12.017_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/gm453","article-title":"Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV\u2212 tumors","volume":"5","author":"Lechner","year":"2013","journal-title":"Genome Med"},{"issue":"7536","key":"10.1016\/j.mayocp.2015.12.017_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.mayocp.2015.12.017_bib22","first-page":"1747","article-title":"Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas","volume":"36","author":"Laubenbacher","year":"1995","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.mayocp.2015.12.017_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2214\/AJR.14.14166","article-title":"Diagnostic accuracy of follow-up FDG PET or PET\/CT in patients with head and neck cancer after definitive treatment: a systematic review and meta-analysis","volume":"205","author":"Sheikhbahaei","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijrobp.2008.07.019","article-title":"Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer\u2014a long-term outcome report","volume":"74","author":"Yao","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.mayocp.2015.12.017_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hed.20130","article-title":"Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer","volume":"27","author":"Porceddu","year":"2005","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.mayocp.2015.12.017_bib26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.6004\/jnccn.2013.0113","article-title":"Head and neck cancers, version 2.2013: featured updates to the NCCN guidelines","volume":"11","author":"Pfister","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.mayocp.2015.12.017_bib27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00405-013-2603-0","article-title":"New treatment strategies for HPV-positive head and neck cancer","volume":"271","author":"Kofler","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.12.017_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hed.21500","article-title":"Transoral robotic surgery and human papillomavirus status: oncologic results","volume":"33","author":"Cohen","year":"2011","journal-title":"Head Neck"},{"issue":"34","key":"10.1016\/j.mayocp.2015.12.017_bib29","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"22","key":"10.1016\/j.mayocp.2015.12.017_bib30","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","article-title":"Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy","volume":"26","author":"Langendijk","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.12.017_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.radonc.2013.12.007","article-title":"Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer","volume":"110","author":"Vlacich","year":"2014","journal-title":"Radiother Oncol"},{"issue":"9208","key":"10.1016\/j.mayocp.2015.12.017_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site","volume":"100","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.12.017_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"issue":"27","key":"10.1016\/j.mayocp.2015.12.017_bib36","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","article-title":"Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522","volume":"32","author":"Ang","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.12.017_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1470-2045(14)71200-8","article-title":"Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial","volume":"16","author":"Giralt","year":"2015","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.mayocp.2015.12.017_bib38","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocp.2015.12.017_bib39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"29","key":"10.1016\/j.mayocp.2015.12.017_bib40","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2015.61.2978","article-title":"Organ preservation for advanced larynx cancer: issues and outcomes","volume":"33","author":"Forastiere","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0360-3016(03)01370-1","article-title":"Radiotherapy with concomitant weekly docetaxel for stages III\/IV oropharynx carcinoma: results of the 98-02 GORTEC Phase II trial","volume":"58","author":"Calais","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2015.12.017_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O'Sullivan","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.mayocp.2015.12.017_bib45","first-page":"5s","article-title":"E1308: Reduced-dose IMRT in human papilloma virus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (cCR) to induction chemotherapy (IC)","volume":"32","author":"Cmelak","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.mayocp.2015.12.017_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1200\/JCO.2014.58.6412","article-title":"Refining American Joint Committee on Cancer\/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas","volume":"33","author":"Huang","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.mayocp.2015.12.017_bib47","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.mayocp.2015.12.017_bib48","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.mayocp.2015.12.017_bib49","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2012.47.7802","article-title":"Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group","volume":"31","author":"Blanchard","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2015.12.017_bib50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1200\/JCO.2012.42.3988","article-title":"Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study","volume":"31","author":"Lefebvre","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.12.017_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1016\/j.mayocp.2015.12.017_bib52","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer","volume":"32","author":"Cohen","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.mayocp.2015.12.017_bib53","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(13)70085-8","article-title":"Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition","volume":"14","author":"Burtness","year":"2013","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2015.12.017_bib54","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/1078-0432.CCR-14-2820","article-title":"A\u00a0phase I study of CUDC-101, a multitarget inhibitor of HDACs, EGFR, and HER2, in combination with chemoradiation in patients with head and neck squamous cell carcinoma","volume":"21","author":"Galloway","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"16","key":"10.1016\/j.mayocp.2015.12.017_bib55","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2006.06.7447","volume":"25","author":"Vermorken","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.mayocp.2015.12.017_bib56","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1158\/1078-0432.CCR-05-1247","article-title":"Phase II trial of gefitinib 250 mg daily in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"11","author":"Cohen","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.mayocp.2015.12.017_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1200\/JCO.2004.06.075","article-title":"Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck","volume":"22","author":"Soulieres","year":"2004","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961501006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961501006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T18:52:36Z","timestamp":1536951156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961501006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S002561961501006X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.12.017","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}